Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2006
Developing better economic models of osteoporosis: considerations for the calculation of the relative risk of fractureDennis M Black, Lisa Palermo, Daniel T Grima
Pharmacoeconomics|March 6, 2007
Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in CanadaDaniel T Grima, Melissa F Thompson, Luc Sauriol
Computational and Mathematical Methods in Medicine|February 1, 2012
Mathematical model of the impact of a nonantibiotic treatment for Clostridium difficile on the endemic prevalence of vancomycin-resistant enterococci in a hospital settingDaniel T Grima, Glenn F Webb, Erika M C D'Agata
Current Medical Research and Opinion|December 24, 2010
Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidneyDaniel T Grima, Parisa Airia, Cheryl Attard, et al.
Journal of Glaucoma|November 16, 2006
Considerations in developing model-based economic evaluations of glaucoma treatmentRikard Althin, Daniel T Grima, Ravinder Dhawan, et al.
Journal of Medical Economics|August 4, 2012
A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United KingdomLisa Bernard, David Mendelssohn, Elizabeth Dunn, et al.
BMC Musculoskeletal Disorders|April 15, 2010
Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort studyDaniel T Grima, Alexandra Papaioannou, Parisa Airia, et al.
Current Medical Research and Opinion|December 11, 2012
Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysisDaniel T Grima, Elizabeth S Dunn, Lisa M Bernard, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 29, 2005
Intraocular pressure control and persistence on treatment in glaucoma and ocular hypertensionDavid Tingey, Lisa M Bernard, Daniel T Grima, et al.
Managed Care (Langhorne, Pa.)|December 15, 2012
How rebates, copayments, and administration costs affect the cost-effectiveness of osteoporosis therapiesNicole C Ferko, Natalie Borisova, Parisa Airia, et al.
Pageof 2